1. Torre, L. A. et al. Global cancer statistics, 2012. Ca-Cancer J. Clin. 65, 87–108 (2015).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. Ca-Cancer J. Clin. 66, 7–30 (2016).
3. Shirasaka, T. et al. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res. 56, 2602–2606 (1996).
4. Tatsumi, K., Fukushima, M., Shirasaka, T. & Fujii, S. Inhibitory effects of pyrimidine, barbituric-acid and pyridine-derivatives on 5-fluorouracil degradation in rat-liver extracts. Jpn. J. Cancer Res. 78, 748–755 (1987).
5. Shirasaka, T., Shimamoto, Y. & Fukushima, M. Inhibition of oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor-activity in rats. Cancer Res. 53, 4004–4009 (1993).